skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Material Type:
Article
Add to My Research

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Nature communications, 2023-04, Vol.14 (1), p.2149-2149, Article 2149 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. corrected publication 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-37417-9 ;PMID: 37069151

Full text available

2
Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models
Material Type:
Article
Add to My Research

Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models

Toxicologic pathology, 2022-04, Vol.50 (3), p.280-293 [Peer Reviewed Journal]

The Author(s) 2022 ;ISSN: 0192-6233 ;EISSN: 1533-1601 ;DOI: 10.1177/01926233211072767

Digital Resources/Online E-Resources

3
Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Material Type:
Article
Add to My Research

Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

Nature communications, 2023-10, Vol.14 (1), p.6211-6211, Article 6211 [Peer Reviewed Journal]

The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Springer Nature Limited 2023 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-023-42061-4 ;PMID: 37798288

Full text available

4
Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges
Material Type:
Article
Add to My Research

Cooperation Between Systemic IgG1 and Mucosal Dimeric IgA2 Monoclonal Anti-HIV Env Antibodies: Passive Immunization Protects Indian Rhesus Macaques Against Mucosal SHIV Challenges

Frontiers in immunology, 2021-08, Vol.12, p.705592-705592 [Peer Reviewed Journal]

Copyright © 2021 Gong, Lakhashe, Hariraju, Scinto, Lanzavecchia, Cameroni, Corti, Ratcliffe, Rogers, Xiao, Fontenot, Villinger and Ruprecht. ;Copyright © 2021 Gong, Lakhashe, Hariraju, Scinto, Lanzavecchia, Cameroni, Corti, Ratcliffe, Rogers, Xiao, Fontenot, Villinger and Ruprecht 2021 Gong, Lakhashe, Hariraju, Scinto, Lanzavecchia, Cameroni, Corti, Ratcliffe, Rogers, Xiao, Fontenot, Villinger and Ruprecht ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.705592 ;PMID: 34413855

Full text available

5
Vaccine Hyporesponse Induced by Individual Antibiotic Treatment in Mice and Non-Human Primates Is Diminished upon Recovery of the Gut Microbiome
Material Type:
Article
Add to My Research

Vaccine Hyporesponse Induced by Individual Antibiotic Treatment in Mice and Non-Human Primates Is Diminished upon Recovery of the Gut Microbiome

Vaccines (Basel), 2021-11, Vol.9 (11), p.1340 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines9111340 ;PMID: 34835271

Full text available

6
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates
Material Type:
Article
Add to My Research

Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates

npj vaccines, 2022-10, Vol.7 (1), p.128-128, Article 128 [Peer Reviewed Journal]

The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00560-3 ;PMID: 36307453

Full text available

7
Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs
Material Type:
Article
Add to My Research

Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs

Pathogens (Basel), 2021-11, Vol.10 (11), p.1441 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2076-0817 ;EISSN: 2076-0817 ;DOI: 10.3390/pathogens10111441 ;PMID: 34832599

Full text available

8
Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
Material Type:
Article
Add to My Research

Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates

Cellular & molecular immunology, 2022-02, Vol.19 (2), p.222-233 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1672-7681 ;EISSN: 2042-0226 ;DOI: 10.1038/s41423-021-00809-2 ;PMID: 34983950

Full text available

9
Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys
Material Type:
Article
Add to My Research

Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys

The American journal of pathology, 2019-10, Vol.189 (10), p.1953-1972 [Peer Reviewed Journal]

2019 American Society for Investigative Pathology ;Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. ;2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. 2019 American Society for Investigative Pathology ;ISSN: 0002-9440 ;EISSN: 1525-2191 ;DOI: 10.1016/j.ajpath.2019.05.013 ;PMID: 31547920

Full text available

10
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article
Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

11
A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates
Material Type:
Article
Add to My Research

A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates

Vaccine, 2018-05, Vol.36 (20), p.2876-2885 [Peer Reviewed Journal]

2018 Merck Sharp & Dohme Corp and The Authors ;Copyright © 2018 Merck Sharp & Dohme Corp and The Authors. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited May 11, 2018 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2018.02.110 ;PMID: 29599087

Full text available

12
Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine
Material Type:
Article
Add to My Research

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine

Vaccine, 2012-12, Vol.30 (51), p.7400-7406 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 7, 2012 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2012.09.083 ;PMID: 23063831

Full text available

13
A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates
Material Type:
Article
Add to My Research

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

bioRxiv, 2022-12

2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2022.12.25.521784

Digital Resources/Online E-Resources

14
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Material Type:
Article
Add to My Research

Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates

bioRxiv, 2021-02

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696

Digital Resources/Online E-Resources

15
Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine
Material Type:
Article
Add to My Research

Durable protection against SARS-CoV-2 Omicron induced by an adjuvanted subunit vaccine

bioRxiv, 2022-03

2022. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2022.03.18.484950

Digital Resources/Online E-Resources

16
BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2
Material Type:
Article
Add to My Research

BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2

bioRxiv, 2020-12

2020. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2020.12.11.421008v1 ;DOI: 10.1101/2020.12.11.421008

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (12)

Searching Remote Databases, Please Wait